Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Delayed Data
As of Oct 05
 +2.01 / +4.93%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 85.00, with a high estimate of 106.00 and a low estimate of 69.00. The median estimate represents a +98.83% increase from the last price of 42.75.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 148.72%


Growthquarterly 2.34%
Growthannually 23.84%
Key to the earnings and sales forecast charts.